Capula Management »

Aclaris Therapeutics shares owned by Capula Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Capula Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $24k 16k 1.53

More positions owned by Capula Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Strategy Cl A New Put Option (MSTR)
UnitedHealth Put Option (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Coinbase Global Com Cl A Call Option (COIN)
Apple (AAPL)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Nike CL B (NKE)
Dell Technologies CL C (DELL)

View all positions for Capula Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Vivo Capital
Vanguard Group
BlackRock
Adage Capital Partners GP
Rock Springs Capital Management
Decheng Capital
Geode Capital Management
D. E. Shaw & Co
Acadian Asset Management
Marshall Wace
Renaissance Technologies
Palo Alto Investors
Millennium Management
Logos Global Management

View all funds holding Aclaris Therapeutics